We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Excision Advised for Papillary Breast Lesions

By HospiMedica staff writers
Posted on 31 Mar 2006
A retrospective study recommends surgical excision of all papillary breast lesions, including benign ones, since diagnosis via core-needle breast biopsy alone was found to be inadequate.

Researchers at New York Presbyterian Hospital at Columbia University (New York, USA) and New York University Medical Center (New York, USA) retrospectively examined the imaging and histologic follow-up findings of 43 biopsies in 42 women who were diagnosed with papillary lesions from 1997-2003 at the two institutions. More...
After core-needle biopsies, 29 lesions were diagnosed as papilloma, eight as sclerosing papilloma, and six as benign papillary lesions not otherwise specified. Clinically, all lesions were nonpalpable, none of the patients had nipple discharge, and all 43 lesions were at least 2 cm from the nipple.

Of the 43 lesions, 36 were excised, and histologic examination showed that 26 were in fact benign. However, eight lesions were upgraded to papilloma with adjacent foci of atypical ductal hyperplasia, and another two to well-differentiated papillary ductal carcinoma in situ (DCIS). One woman had two tissue samples upgraded. In other words, 21.4% of the patients (nine of 42) actually had an atypical or malignant lesion. The results were reported in the March 2006 issue of Radiology.

All benign papillary lesions of the breast should be surgically excised, since a considerable number of atypical lesions and malignant lesions could be missed, said lead author Cecilia Mercado, M.D., of New York University Medical Center. In fact, she and her colleagues argue, the risk may be even greater than was shown because the study excluded women with nipple discharge or palpable masses.



Related Links:
New York Presbyterian Hospital
New York University Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.